Geisinger's biosimilar strategy, Tamiflu in shortage & drug pricing shifts.

January 8, 2026

1. Why Geisinger went biosimilar-1st across its pharmacy portfolio Full story

2. Tamiflu in shortage Full story

3. AI is helping predict med inventory risks early — before stockouts hit. See how: here.

 

4. Jefferson Health sues drugmakers, PBMs over insulin pricing Full story

5. 10 hospitals, health systems seeking pharmacy leaders Full story

6. Drug shortages are daily threats. UVA Health shows their strategies to restore control here.

 

7. Drugmakers recalibrate pricing strategies for Medicare Full story

8. GLP-1 adherence lags among older adults: 6 notes Full story

9. California hospital could close Jan. 10 Full story

10. Flu strains hospital capacity Full story

11. US companies are scaling back hiring in 2026. How do hospitals compare? Full story

 

12. 70% of admissions handled virtually helped NMHS strengthen retention and throughput here.

Becker's Learning Opportunities

13. How are peers making purchasing calls ahead of 2026? Benchmark your strategy here.

14. Alternative pricing beyond rebates is rising. Get the executive summary here.

15. Pharmacy blind spots are draining margins. How Texas Children's closed the gap, here.

16. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 

 

Contact Us, Feedback, or Questions – Email ptwenter@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication